...
首页> 外文期刊>Medical hypotheses >Identification of gene markers based on well validated and subcategorized stressed animals for potential clinical applications in PTSD.
【24h】

Identification of gene markers based on well validated and subcategorized stressed animals for potential clinical applications in PTSD.

机译:根据经过充分验证和分类的应激动物识别基因标记物,以用于PTSD中的潜在临床应用。

获取原文
获取原文并翻译 | 示例
           

摘要

Post-traumatic stress disorder (PTSD) is a complex mental disorder that can develop in response to traumatic experiences. The molecular mechanisms underlying the pathology of PTSD are poorly understood, and this lack of knowledge hampers our ability to find superior therapeutic approaches to the treatment of this disorder. There are two main reasons for our lack of study in this area: here is no sufficiently validated animal model and lack of large-scale studies for the search of underlying molecular mechanisms. Thus, to promote research on PTSD (especially its molecular mechanisms) and to set molecular basis for searching novel medications of this disorder, large-scale, genome-wide interrogation of a significant amount of genes based upon a well validated animal model is demanded. We hypothesize that a significant number of genes are involved in PTSD. It is only with a large number of these genes identified in specific samples of PTSD-related population, and then it is possible for a sufficient understanding of the pathology at the molecular level of a PTSD, as well as for enhancing the PTSD's therapeutic and preventative strategies. Two prerequisites are needed for testing this hypothesis: (1) relative pure samples from a well validated animal model; and (2) genome-wide screening of PTSD molecular targets. For the animal model, we suggest to use the predator-exposure paradigm, in which rats are exposed to a predator, this model has previously been evaluated behaviorally well emulated the clinical symptoms of PTSD. For a better stringency, three criteria can be used to further validate this animal model: analogous (similarity of behavior), predictive (predictability of drug response) and biological mechanism (e.g., electrophysiological and pathological change in amygdala). For large-scale molecular target screening, the new microarray technology, which can profile expression of tens of thousands genes simultaneously, is the method of choice. The validity and practicability of this hypothesis and thestrategy for its testing have been supported by our preliminary laboratory data.
机译:创伤后应激障碍(PTSD)是一种复杂的精神障碍,可因创伤经历而发展。创伤后应激障碍的病理学的分子机制了解甚少,这种知识的缺乏阻碍了我们寻找更好的治疗方法来治疗这种疾病的能力。我们在该领域缺乏研究的主要原因有两个:这里没有经过充分验证的动物模型,也缺乏大规模的研究来寻找潜在的分子机制。因此,为了促进对PTSD的研究(特别是其分子机制)并为寻找该疾病的新药奠定分子基础,需要基于充分验证的动物模型的大规模全基因组研究。我们假设PTSD中涉及大量基因。只有在PTSD相关人群的特定样本中鉴定出大量这些基因,然后才有可能在PTSD分子水平上充分了解病理学,以及增强PTSD的治疗和预防作用策略。测试该假设需要两个先决条件:(1)来自经过充分验证的动物模型的相对纯净的样品; (2)全基因组筛选PTSD分子靶标。对于动物模型,我们建议使用将大鼠暴露于捕食者的捕食者-暴露范式,该模型先前已通过行为评估得到了良好的模拟PTSD的临床症状。为了获得更好的严格性,可以使用三个标准来进一步验证该动物模型:类似(行为相似),可预测(药物反应的可预测性)和生物学机制(例如杏仁核的电生理和病理变化)。对于大规模分子靶标筛选,可以同时分析数万个基因表达的新型微阵列技术是首选方法。我们的初步实验室数据支持了该假设及其测试策略的有效性和实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号